About The Study: Follow-up of youth with pre-symptomatic type 1 diabetes demonstrated that the COVID-19 pandemic was associated with an accelerated progression to clinical disease and that this acceleration was confined to those with COVID-19. Further studies are required to determine whether COVID-19 also accelerates progression to type 1 diabetes in adults and whether vaccination and monitoring for COVID-19 symptoms should be considered for individuals with pre-symptomatic type 1 diabetes.
Corresponding Author: To contact the corresponding author, Anette-Gabriele Ziegler, M.D., email anettegabriele.ziegler@helmholtz-munich.de.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.11174)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11174?guestAccessKey=26c76ca0-e27f-4e62-8c40-fc63e2f9bba9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071524
Journal
JAMA